Have You Experienced...
- Chronic congestion or post-nasal drip for more than 12 weeks
- Recurrent sinus infections that come back after each antibiotic course
- Loss of smell that doesn't fully recover after each infection
- Pressure or facial pain even when imaging shows no acute infection
- Symptoms worse at home, in a specific building, or in damp weather
- Sinus surgery that didn't fix the underlying problem
- Sinus symptoms alongside fatigue, brain fog, or joint pain
- Throat clearing, hoarseness, or a constant cough at night
Quick Answer
Most chronic sinus infection isn't ordinary bacterial sinusitis — it's a fungal biofilm and inflammatory response, frequently driven by mold exposure. MARCoNS (multiple antibiotic-resistant coagulase-negative staph) colonizes the deep nasopharynx and produces biotoxins that block recovery. Standard antibiotics miss both targets entirely. The Houston region's year-round humidity makes mold-driven chronic sinusitis especially common locally.
What's Actually Driving Chronic Sinusitis
Fungal biofilm
Landmark Mayo Clinic research found fungal organisms in 96% of chronic sinusitis cases. The body's eosinophilic response to the fungus drives inflammation — antibiotics don't help because the target isn't bacterial.
MARCoNS
Multiple antibiotic-resistant coagulase-negative staph colonizes the deep nasopharynx in roughly 80% of CIRS patients. It produces biotoxins that suppress MSH and block recovery from mold illness.
Mycotoxin exposure
Inhaled mold toxins inflame the sinus mucosa directly. Patients often notice sinus symptoms flare in specific buildings. More on mold →
Mast cell activation
Sinus tissue is rich in mast cells. MCAS produces non-allergic rhinitis, post-nasal drip, and congestion that swings with triggers. More on MCAS →
Why ENT and Antibiotics Don't Solve It
The standard chronic sinusitis pathway looks like: antibiotics → repeat antibiotics → steroid nasal spray → surgery. It works short-term and then it doesn't, because:
- Antibiotics don't touch fungus or biofilm
- MARCoNS is, by definition, antibiotic-resistant
- Surgery removes anatomy but not the organisms — they recolonize
- The upstream cause (mold in the building you live or work in) is never investigated
Sinuses won't quit?
It's almost never just sinuses. Our assessment maps your exposure history.
Testing
- Deep nasopharyngeal swab culture — MARCoNS detection and fungal speciation
- Mycotoxin urine panel — establishes systemic mold exposure
- CIRS biomarkers — TGF-β, MMP-9, C3a, C4a, MSH, VIP
- Environmental inspection — ERMI or HERTSMI-2 dust testing of home and workplace
- Visual contrast sensitivity (VCS) — neurological screen for biotoxin illness
Treatment That Targets the Cause
Effective treatment is multi-layered. We typically see significant improvement within 8–12 weeks once the actual organisms are addressed.
- Targeted antimicrobial nasal therapy. BEG (Bactroban-EDTA-gentamicin) spray for MARCoNS, antifungal nasal compounds for fungal biofilm.
- Biofilm disruption. EDTA, xylitol nasal sprays, mechanical irrigation.
- Environmental remediation. Removing mold exposure is non-negotiable — sinus treatment fails as long as ongoing exposure continues.
- Calm mast cells if present. H1/H2 blockers, cromolyn nasal spray during recovery.
- Systemic CIRS treatment. Binders, VIP nasal spray for select patients, MSH restoration — the broader picture that prevents recurrence.
Frequently Asked Questions
In most cases, yes. Mayo Clinic research in 1999 demonstrated fungal organisms in 96% of chronic rhinosinusitis cases. The driving problem isn't fungal infection per se but the body's eosinophilic immune response to the fungus — which is why antibiotics don't help and antifungal/anti-inflammatory approaches do.
Multiple antibiotic-resistant coagulase-negative Staphylococcus — a strain of staph that colonizes the deep nasopharynx and produces biotoxins. It's resistant to standard antibiotics and is identified in roughly 80% of CIRS patients. Treatment requires specialized compounded nasal sprays (BEG) rather than systemic antibiotics.
Functional Endoscopic Sinus Surgery (FESS) helps anatomy and short-term symptoms but rarely resolves chronic sinusitis when the underlying cause is fungal biofilm or MARCoNS. Patients commonly recur within 12–18 months unless the organisms are treated and the upstream mold exposure is addressed.
Year-round humidity, frequent flooding, and heavy use of air conditioning create the conditions for mold growth in residential and commercial buildings. Many Houston-area patients we see have ERMI scores indicating significant mold exposure in their homes — even when the home looks clean and dry to the eye.